New setback for angiogenesis inhibitors

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1369, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 241-253

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis Inhibitors: New Agents in Cancer Therapy

By Ryan C.J.

Drugs & Aging, Vol. 17, Iss. 4, 2000-10 ,pp. : 249-255

Adis International

Access to resources Recommend Favorite

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

By Tomao Federica Papa Anselmo Rossi Luigi Caruso Davide Zoratto Federica Benedetti Panici Pierluigi Tomao Silverio

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 37-53

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay Hoff Paulo M

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite

Breakthrough for angiogenesis inhibitors

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite